Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Blank Check IPOs (SPACS) -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (2074)	11/22/2015 3:56:53 PM
From: Glenn Petersen	Respond to of 3862

In October 2015, IBM Corporation completed the acquisition of Merge Healthcare (stock symbol: MRGE) for $7.13 per share. CEA Acquisition raised $24.15 million when it went public on February 13, 2004. On February 9, 2006, the company completed the acquisition of etrials Worldwide (stock symbol: ETWC), a global provider of integrated software for the life sciences industry, On June 1, 2009, etrials Worldwide agreed to be acquired by Merge Technologies (stock symbol: MRGE) in a cash/stock deal valued at $1.70 ($.80 in cash and .3448 shares of MRGE). The IBMI acquisition values the original CEA Acquisition shares at $3.26 each. Under the terms of the Merger Agreement, at the effective time of the Merger, each share of (i) common stock of Merge, $0.01 par value per share (“Merge Common Stock”), issued and outstanding immediately prior to the effective time of the Merger was converted into the right to receive $7.13 in cash (the “Common Stock Merger Consideration”) and (ii) Series A Convertible Preferred Stock of Merge, $0.01 par value per share (“Merge Preferred Stock”), issued and outstanding immediately prior to the effective time of the Merger was converted into the right to receive $1500.00 in cash; in each case, without interest and less any applicable withholding taxes. sec.gov